Group One Trading’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$520 Hold
400
﹤0.01% 7289
2026
Q1
$580 Sell
400
-14,600
-97% -$23.1K ﹤0.01% 7306
2025
Q4
$20.7K Buy
15,000
+8,100
+117% +$16.9K ﹤0.01% 6314
2025
Q3
$18.8K Sell
6,900
-19,600
-74% -$69.6K ﹤0.01% 6737
2025
Q2
$92.5K Sell
26,500
-4,200
-14% -$16.6K ﹤0.01% 5037
2025
Q1
$113K Buy
+30,700
New +$112K ﹤0.01% 4497
2023
Q3
Sell
-9,900
Closed -$21.3K 8267
2023
Q2
$21.3K Sell
9,900
-100
-1% -$243 ﹤0.01% 5956
2023
Q1
$29.1K Buy
+10,000
New +$50.4K ﹤0.01% 5265
2022
Q4
Sell
-10,000
Closed -$32K 8054
2022
Q3
$32K Buy
+10,000
New +$36.3K ﹤0.01% 5761
2021
Q4
Sell
-200
Closed -$1K 8813
2021
Q3
$1K Sell
200
-400
-67% -$3.84K ﹤0.01% 8045
2021
Q2
$10K Buy
+600
New +$8.29K ﹤0.01% 7533

Other funds holding STIM

Group One Trading's STIM Position: Q2 2026 in Review

Group One Trading reduced its Neuronetics (STIM) stake by 24% in Q2 2026, selling an estimated $7.95K and leaving 17,669 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #5923.

Group One Trading first reported a position in STIM in Q1 2021 and has held it in 10 quarters since. The position peaked at $262K in Q3 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Group One Trading held 17,669 shares of Neuronetics worth $23K as of Q2 2026.
  • Group One Trading sold 5,467 Neuronetics shares in Q2 2026, an estimated $7.95K.
  • Neuronetics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5923 holding.
  • Group One Trading first reported a position in Neuronetics in Q1 2021 and has held it in 10 quarters since.
  • Group One Trading's Neuronetics position peaked at $262K in Q3 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.